What happened with MNDR today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Patients use Mobile-health Network Solutions’ MaNaDr app and website to consult doctors about common illnesses, chronic conditions and wellness needs. Doctors can provide prescriptions or refer patients for further examination. Private-sector teleconsultations generate most of the company’s revenue, and patients generally pay directly by credit card rather than seeking reimbursement from another payer.
A smaller business sells medicines and medical devices. MaNaPharma buys products from suppliers and sells them to clinics and other healthcare providers. MaNaShop/MaNaStore sells health products and services to consumers, both directly and through third-party vendors that pay marketplace commissions.
The business depends on patients returning for consultations, reliable technology and the doctors who deliver care. Medical licensing also limits its operations: Singapore’s Ministry of Health revoked MaNaDr Clinic Pte Ltd’s outpatient medical-services license. This concerns the named clinic, rather than a stated platform-wide ban. Its licensed pharmaceutical-wholesale business may sell only to eligible purchasers.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Mobile-health Network Solutions’ results hinge mainly on private MaNaDr’s teleconsultation volumes and its ability to provide licensed medical services after MaNaDr Clinic’s outpatient license was revoked, rather than on any company in this list.
No upcoming items to show.
Earnings, filings and other dated events show up here once their dates are set.
